Skip to search form
Skip to main content
Skip to account menu
Semantic Scholar
Semantic Scholar's Logo
Search 236,570,914 papers from all fields of science
Search
Sign In
Create Free Account
selexipag
Known as:
2-(4-((5,6-diphenylpyrazin-2-yl)(isopropyl)amino)butoxy)-N-(methylsulfonyl)acetamide
National Institutes of Health
Create Alert
Alert
Related topics
Related topics
6 relations
Narrower (3)
ACT 293987
NS-304
Uptravi
Broader (3)
Acetamides
Antihypertensive Agents
Pyrazines
Papers overview
Semantic Scholar uses AI to extract papers important to this topic.
2018
2018
Abstract 14975: Transitioning Parenteral Prostacyclin Analogs to Selexipag in Pulmonary Arterial Hypertension
N. Shelburne
,
K. Parikh
,
Karla Kennedy
,
T. Dahhan
,
T. Fortin
,
S. Rajagopal
2018
Corpus ID: 209253233
Introduction: Selexipag, an oral selective prostacyclin receptor agonist, delays disease progression versus placebo in pulmonary…
Expand
2017
2017
The Selective Prostacyclin (Ip) Receptor Agonist Selexipag: A Promising Drug in Pediatric Pulmonary Artery Hypertension
M. Koestenberger
,
H. Sallmon
,
G. Hansmann
2017
Corpus ID: 13686316
1Division of Pediatric Cardiology, Department of Pediatrics, Medical University Graz, Austria 2Department of Neonatology, Charit…
Expand
2017
2017
Pulmonary Vascular Defects in Congenital Diaphragmatic Hernia : the quest for early factors and intervention : Pulmonale vasculaire defecten in congenitale hernia diafragmatica : de zoektocht naar…
D. Mous
2017
Corpus ID: 79746926
markdownabstractCongenital diaphragmatic hernia (CDH) is a severe anomaly characterized by a diaphragmatic defect, lung…
Expand
2016
2016
Synthetic method of selexipag
李兴民
2016
Corpus ID: 106200113
The invention discloses a synthetic method of selexipag. According to the method, 4-[(t-butyloxycarboryl)(isopropyl) amino]-1…
Expand
2016
2016
Absolute oral bioavailability of selexipag, a novel oral prostacyclin IP receptor agonist
P. Kaufmann
,
N. Hurst
,
B. Astruc
,
J. Dingemanse
European Journal of Clinical Pharmacology
2016
Corpus ID: 253767116
The aim of this single-center, open-label study was to assess the absolute bioavailability of an oral (tablet) versus intravenous…
Expand
2016
2016
Formes à l'état solide de selexipag
Nidia Villalva
,
Ivon Cante
,
+7 authors
N. López
2016
Corpus ID: 102989387
La presente invention concerne des formes a l'etat solide de selexipag, en particulier des formes IV et V de selexipag, et des…
Expand
2016
2016
Pharmaceutical Approval Update.
M. Goldenberg
P & T : a peer-reviewed journal for formulary…
2016
Corpus ID: 19899254
Lesinurad (Zurampic) for gout-related hyperuricemia; selexipag (Uptravi) for pulmonary arterial hypertension; sugammadex (Bridion…
Expand
2015
2015
Drugs in Clinical Development for Pulmonary Hypertension: Summary and Table
Pharmaceutical Medicine
2015
Corpus ID: 256378203
2015
2015
Multicellular Inputs Regulating Muscle Excitability Symposium Granlibakken Tahoe, Tahoe City, California June 14-17, 2015 Symposium on Multicellular inputs Regulating Muscle Excitability
M. Takeya
,
T. Kanazawa
,
S. Iino
2015
Corpus ID: 48449145
1 Integrin Adhesions and the Myogenic Response of Rat Cerebral Arteries Colinas O, Moreno-Dominguez A, Zhu H-L, Zhong XZ, Walsh…
Expand
2011
2011
PHARMACOKINETICS AND TOLERABILITY OF THE ORAL SELECTIVE PROSTACYCLIN RECEPTOR AGONIST SELEXIPAG AFTER MULTIPLE-DOSE ADMINISTRATION IN HEALTHY MALE SUBJECTS
H. Mukai
,
J. Dingemanse
,
T. Mant
,
P. Sidharta
,
K. Okubo
,
P. Kaufmann
2011
Corpus ID: 74677481